Home/Filings/4/0001415889-25-018822
4//SEC Filing

ROCKLAGE SCOTT M 4

Accession 0001415889-25-018822

CIK 0001689375other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 8:32 PM ET

Size

22.4 KB

Accession

0001415889-25-018822

Insider Transaction Report

Form 4
Period: 2025-06-27
Transactions
  • Sale

    Common Stock

    2025-06-27$6.91/sh55,735$385,1293,220,287 total
  • Sale

    Common Stock

    2025-06-30$6.81/sh18,578$126,5663,201,709 total
  • Sale

    Common Stock

    2025-07-01$7.12/sh6,422$45,7411,100,248 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-06-27$6.91/sh19,265$133,1211,113,092 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-06-30$6.81/sh6,422$43,7511,106,670 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-07-01$7.12/sh18,578$132,3243,183,131 total
Transactions
  • Sale

    Common Stock

    2025-06-30$6.81/sh6,422$43,7511,106,670 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-07-01$7.12/sh18,578$132,3243,183,131 total
  • Sale

    Common Stock

    2025-06-30$6.81/sh18,578$126,5663,201,709 total
  • Sale

    Common Stock

    2025-07-01$7.12/sh6,422$45,7411,100,248 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-06-27$6.91/sh19,265$133,1211,113,092 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-06-27$6.91/sh55,735$385,1293,220,287 total
Transactions
  • Sale

    Common Stock

    2025-07-01$7.12/sh18,578$132,3243,183,131 total
  • Sale

    Common Stock

    2025-07-01$7.12/sh6,422$45,7411,100,248 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-06-27$6.91/sh19,265$133,1211,113,092 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-06-30$6.81/sh18,578$126,5663,201,709 total
  • Sale

    Common Stock

    2025-06-30$6.81/sh6,422$43,7511,106,670 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-06-27$6.91/sh55,735$385,1293,220,287 total
Transactions
  • Sale

    Common Stock

    2025-06-30$6.81/sh6,422$43,7511,106,670 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-06-27$6.91/sh19,265$133,1211,113,092 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-06-27$6.91/sh55,735$385,1293,220,287 total
  • Sale

    Common Stock

    2025-07-01$7.12/sh6,422$45,7411,100,248 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-06-30$6.81/sh18,578$126,5663,201,709 total
  • Sale

    Common Stock

    2025-07-01$7.12/sh18,578$132,3243,183,131 total
Transactions
  • Sale

    Common Stock

    2025-06-27$6.91/sh55,735$385,1293,220,287 total
  • Sale

    Common Stock

    2025-06-30$6.81/sh18,578$126,5663,201,709 total
  • Sale

    Common Stock

    2025-06-27$6.91/sh19,265$133,1211,113,092 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-07-01$7.12/sh18,578$132,3243,183,131 total
  • Sale

    Common Stock

    2025-06-30$6.81/sh6,422$43,7511,106,670 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-07-01$7.12/sh6,422$45,7411,100,248 total(indirect: By 5AM Opportunities I, L.P.)
Transactions
  • Sale

    Common Stock

    2025-06-27$6.91/sh19,265$133,1211,113,092 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-06-30$6.81/sh18,578$126,5663,201,709 total
  • Sale

    Common Stock

    2025-06-30$6.81/sh6,422$43,7511,106,670 total(indirect: By 5AM Opportunities I, L.P.)
  • Sale

    Common Stock

    2025-07-01$7.12/sh18,578$132,3243,183,131 total
  • Sale

    Common Stock

    2025-06-27$6.91/sh55,735$385,1293,220,287 total
  • Sale

    Common Stock

    2025-07-01$7.12/sh6,422$45,7411,100,248 total(indirect: By 5AM Opportunities I, L.P.)
Footnotes (2)
  • [F1]Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports.
  • [F2]Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports.

Issuer

Entrada Therapeutics, Inc.

CIK 0001689375

Entity typeother

Related Parties

1
  • filerCIK 0001219014

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 8:32 PM ET
Size
22.4 KB